Fierce JPM Week - Virtual Agenda has ended
Back To Schedule
Thursday, January 20 • 11:10am - 11:30am
R&D in an Age of Multiplying Modalities and Targets

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

mRNA is the latest in a wave of new modalities that expand our ability to intervene in disease. Even established modalities see a broadening reach as omics and AI-enabled discovery open new targets and diseases to attack. The multiplicative expansion of modalities, targets, and diseases creates many new opportunities but challenges the traditional blockbuster model. We examine the evolution of the R&D landscape and its drivers, as the number and diversity of approaches grow and consider implications for development strategy, clinical trials, and ROI.

avatar for Michael Ward

Michael Ward

Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate
Mike Ward serves as Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate. As both an award-winning journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership... Read More →
avatar for Kenneth Beers, Ph.D.

Kenneth Beers, Ph.D.

Partner-Consulting, Clarivate
Ken is a Partner in Clarivate’s Commercial Consulting practice serving life sciences clients on matters related to portfolio strategy and asset development and commercialization. Ken works closely with Clarivate data analytics and bioinformatics experts to bring scientific, clinical... Read More →

Thursday January 20, 2022 11:10am - 11:30am EST